IBDEI1RU ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28296,0)
 ;;=F02.81^^115^1386^14
 ;;^UTILITY(U,$J,358.3,28296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28296,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/ Behav Dist
 ;;^UTILITY(U,$J,358.3,28296,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,28296,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,28297,0)
 ;;=F02.80^^115^1386^15
 ;;^UTILITY(U,$J,358.3,28297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28297,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/o Behav Dist
 ;;^UTILITY(U,$J,358.3,28297,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,28297,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,28298,0)
 ;;=A81.01^^115^1386^9
 ;;^UTILITY(U,$J,358.3,28298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28298,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,28298,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,28298,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,28299,0)
 ;;=F05.^^115^1386^13
 ;;^UTILITY(U,$J,358.3,28299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28299,1,3,0)
 ;;=3^Delirium d/t Physiological Cond
 ;;^UTILITY(U,$J,358.3,28299,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,28299,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,28300,0)
 ;;=R41.0^^115^1386^19
 ;;^UTILITY(U,$J,358.3,28300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28300,1,3,0)
 ;;=3^Disorientation,Unspec
 ;;^UTILITY(U,$J,358.3,28300,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,28300,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,28301,0)
 ;;=G31.09^^115^1386^20
 ;;^UTILITY(U,$J,358.3,28301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28301,1,3,0)
 ;;=3^Frontotemporal Disease
 ;;^UTILITY(U,$J,358.3,28301,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,28301,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,28302,0)
 ;;=G90.3^^115^1386^24
 ;;^UTILITY(U,$J,358.3,28302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28302,1,3,0)
 ;;=3^Multi-System Degeneration of Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,28302,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,28302,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,28303,0)
 ;;=A81.9^^115^1386^28
 ;;^UTILITY(U,$J,358.3,28303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28303,1,3,0)
 ;;=3^Prion Disease
 ;;^UTILITY(U,$J,358.3,28303,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,28303,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,28304,0)
 ;;=S06.2X9S^^115^1386^31
 ;;^UTILITY(U,$J,358.3,28304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28304,1,3,0)
 ;;=3^TBI,Diffuse w/ Unspec Duration of LOC,Sequela
 ;;^UTILITY(U,$J,358.3,28304,1,4,0)
 ;;=4^S06.2X9S
 ;;^UTILITY(U,$J,358.3,28304,2)
 ;;=^5020755
 ;;^UTILITY(U,$J,358.3,28305,0)
 ;;=R41.9^^115^1386^25
 ;;^UTILITY(U,$J,358.3,28305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28305,1,3,0)
 ;;=3^Neurocognitive D/O,Unspec
 ;;^UTILITY(U,$J,358.3,28305,1,4,0)
 ;;=4^R41.9
 ;;^UTILITY(U,$J,358.3,28305,2)
 ;;=^5019449
 ;;^UTILITY(U,$J,358.3,28306,0)
 ;;=F01.50^^115^1386^33
 ;;^UTILITY(U,$J,358.3,28306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28306,1,3,0)
 ;;=3^Vascular Dementia w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,28306,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,28306,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,28307,0)
 ;;=F06.31^^115^1387^1
 ;;^UTILITY(U,$J,358.3,28307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28307,1,3,0)
 ;;=3^Depress D/O d/t Anth Med Cond w/ Dep Feat
 ;;^UTILITY(U,$J,358.3,28307,1,4,0)
 ;;=4^F06.31
 ;;^UTILITY(U,$J,358.3,28307,2)
 ;;=^5003057
 ;;^UTILITY(U,$J,358.3,28308,0)
 ;;=F06.32^^115^1387^2
